Elisabeth Leann Mcclure is a Normal, Illinois based nurse practitioner. Active license number of Elisabeth Leann Mcclure is 209025593 in Illinois. Her current practice location is 1302 Franklin Ave, Normal. Patients can reach her at 309-268-6300. Elisabeth Leann Mcclure is FNP APN and her NPI number (Unique professional ID assigned by NPPES) is 1609504109. Elisabeth Leann Mcclure has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Elisabeth Leann Mcclure speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1609504109
NPI Enumeration Date:
11 Aug, 2022
NPI Last Update On:
21 Nov, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elisabeth Leann Mcclure are as mentioned below.
License Number
Specialization
State
Status
209025593
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Elisabeth Leann Mcclure 1019 N Oak St, Normal, Illinois
Zip:
61761-1735
Phone Number:
309-265-5794
Patients can reach Elisabeth Leann Mcclure at 1302 Franklin Ave, Normal, Illinois or can call to book an appointment on 309-268-6300.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.